These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19177197)

  • 1. Aberrant promoter methylation of SPARC in ovarian cancer.
    Socha MJ; Said N; Dai Y; Kwong J; Ramalingam P; Trieu V; Desai N; Mok SC; Motamed K
    Neoplasia; 2009 Feb; 11(2):126-35. PubMed ID: 19177197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response.
    Cheetham S; Tang MJ; Mesak F; Kennecke H; Owen D; Tai IT
    Br J Cancer; 2008 Jun; 98(11):1810-9. PubMed ID: 18458674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways.
    Tomar T; de Jong S; Alkema NG; Hoekman RL; Meersma GJ; Klip HG; van der Zee AG; Wisman GB
    Genome Med; 2016 Oct; 8(1):107. PubMed ID: 27765068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant methylation of the SPARC gene promoter and its clinical implication in gastric cancer.
    Chen ZY; Zhang JL; Yao HX; Wang PY; Zhu J; Wang W; Wang X; Wan YL; Chen SW; Chen GW; Liu YC
    Sci Rep; 2014 Dec; 4():7035. PubMed ID: 25516351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of the SPARC promoter and its prognostic value for prostate cancer.
    Liu T; Qiu X; Zhao X; Yang R; Lian H; Qu F; Li X; Guo H
    Oncol Rep; 2018 Feb; 39(2):659-666. PubMed ID: 29207175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent inactivation of SPARC by promoter hypermethylation in colon cancers.
    Yang E; Kang HJ; Koh KH; Rhee H; Kim NK; Kim H
    Int J Cancer; 2007 Aug; 121(3):567-75. PubMed ID: 17397030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant methylation of SPARC in human hepatocellular carcinoma and its clinical implication.
    Zhang Y; Yang B; Du Z; Bai T; Gao YT; Wang YJ; Lou C; Wang FM; Bai Y
    World J Gastroenterol; 2012 May; 18(17):2043-52. PubMed ID: 22563191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway.
    Wang Z; Li M; Lu S; Zhang Y; Wang H
    Cancer Biol Ther; 2006 Mar; 5(3):256-60. PubMed ID: 16418574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disfigurement of p16INK4A gene expression in development of ovarian cancer and the mechanism].
    Li M; Huang ZJ; Dong WH; Li XY; Wang XY; He XH; Wang H; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):408-12. PubMed ID: 16831366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic and genetic alterations of p33ING1b in ovarian cancer.
    Shen DH; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Ip P; Cheung AN
    Carcinogenesis; 2005 Apr; 26(4):855-63. PubMed ID: 15677627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP].
    Meng CF; Dai DQ; Guo KJ
    Ai Zheng; 2008 Dec; 27(12):1251-5. PubMed ID: 19079988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.
    Borges S; Döppler H; Perez EA; Andorfer CA; Sun Z; Anastasiadis PZ; Thompson E; Geiger XJ; Storz P
    Breast Cancer Res; 2013 Aug; 15(2):R66. PubMed ID: 23971832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation of secreted protein acidic and rich in cysteine gene and its significance in gastric cancer.
    Shao S; Zhou NM; Dai DQ
    World J Gastroenterol; 2019 Dec; 25(46):6713-6727. PubMed ID: 31857774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer.
    Sheng X; Li J; Yang L; Chen Z; Zhao Q; Tan L; Zhou Y; Li J
    Oncol Rep; 2014 Jul; 32(1):277-85. PubMed ID: 24859196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter methylation status of the Cyclin D2 gene is associated with poor prognosis in human epithelial ovarian cancer.
    Sakuma M; Akahira J; Ito K; Niikura H; Moriya T; Okamura K; Sasano H; Yaegashi N
    Cancer Sci; 2007 Mar; 98(3):380-6. PubMed ID: 17270028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.
    Roll JD; Rivenbark AG; Jones WD; Coleman WB
    Mol Cancer; 2008 Jan; 7():15. PubMed ID: 18221536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation of the PTEN gene in ovarian cancer cell lines.
    Schöndorf T; Ebert MP; Hoffmann J; Becker M; Moser N; Pur S; Göhring UJ; Weisshaar MP
    Cancer Lett; 2004 Apr; 207(2):215-20. PubMed ID: 15072831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
    Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers.
    Takada T; Yagi Y; Maekita T; Imura M; Nakagawa S; Tsao SW; Miyamoto K; Yoshino O; Yasugi T; Taketani Y; Ushijima T
    Cancer Sci; 2004 Sep; 95(9):741-4. PubMed ID: 15471560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reversal effect of 5-aza-2-deoxycytidine on the maternally expressed gene 3 promoter hypermethylation and its inhibitory effect on the proliferation of epithelial ovarian cancer cells].
    Li J; Zhou D; Wang Z; Tan L; Zhou Y; Li J; Sheng X
    Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):324-9. PubMed ID: 26463020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.